SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >


Add AVXT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator marketraider, johnny canuck, Rookiemove
Search This Board:
Last Post: 10/7/2015 9:35:38 AM - Followers: 30 - Board type: Free - Posts Today: 0


Industry Center - Biotechnology

Contact Information
Address: 2000 Hamilton St., Ste. 204
Philadelphia, PA 19130
Phone: 215-241-9760
Fax: 215-241-9684
Key People
Chairman and CEO: John K. A. Prendergast
CFO and Director: Richard P. (Rich) Rainey
AVAX Technologies wants to turn cancer cells into cancer fighters. The company is developing vaccines created by extracting a patient's own cancer cells and chemically treating them to induce an immune system response. The technology used to create the vaccines (called AC Vaccine) is licensed from Thomas Jefferson University. AVAX's lead vaccine candidate MVax is intended as a treatment for late-stage melanoma. The company is also developing vaccine candidates to fight ailments such as ovarian cancer (OVax) and non-small cell lung cancer (LungVax).
Business Summary  

AVAX Technologies, Inc., a development stage biotechnology company, together with its subsidiaries, engages in the development and future commercialization of individualized vaccine therapies and other technologies for the treatment of cancer in the United States and Europe. The company's autologous cell vaccine candidates include M-Vax under Phase III clinical status, which is used for the treatment of melanoma; L-Vax under Phase I-II clinical status that is used for the treatment of non-small cell lung cancer; and O-Vax under Phase I-II clinical status, which is used for the treatment of ovarian cancer. It also offers biological manufacturing services to other biotechnology and pharmaceutical companies; and contract manufacturing services in for cell and gene therapy, and biological products in France. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.


AVAX Technologies, Inc. Files Form 10 With SEC

Press Release Source: AVAX Technologies, Inc. On Friday February 4, 2011, 12:41 pm EST

PHILADELPHIA, Feb. 4, 2011 /PRNewswire/ -- AVAX Technologies, Inc. (Pink - News) ("AVAX" or the "Company") today announced that it filed a Form 10 with the Securities and Exchange Commission ("SEC").  Upon the effectiveness of this Form 10, AVAX will once again become a publicly reporting company.  The Company intends to seek to have its common stock trade on the Over-the-Counter Bulletin Board.

The Company's Form 10, which contains among other things, recent information about the Company's business, operations, financial results and capitalization, can be accessed through the website maintained by the SEC at

About AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company headquartered in Philadelphia, PA.   The Company is engaged in the research and clinical and commercial development of biological products and cancer therapeutics.

The Company's AC Vaccine platform is a therapeutic cancer vaccine.

Forward-Looking Statements

Certain statements in this release are "forward-looking" statements.   Forward-looking statements involve significant risks and uncertainties, and in light of the significant uncertainties inherent in such statements, the inclusion of such information should not be regarded as a representation by the Company that the objectives and plans of the Company will be achieved. In fact, actual results could differ materially from those contemplated by such forward-looking statements. These statements include, but are not limited to, the Company's immediate need to obtain additional funding to continue to finance the Company, the Company's plans, objectives, projections, expectations and intentions such as those relating to the future development of M-VAX® and its other vaccine candidates, as well as other important factors discussed in the Company's Form 10.   The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements or to reflect the occurrence of unanticipated events. 

Press Releases & AVAX Information:

2/4/2001: AVAX Technologies, Inc. Files Form 10 With SEC

AVAX Announces Settlement Agreement with Cancer Treatment Centers of America and Approves $45 Million Private Placement Financing


Published: Aug 4, 2015 7:31 p.m. ET


PHILADELPHIA, Aug 04, 2015 (BUSINESS WIRE) -- AVAX Technologies, Inc., (“AVAX” or “The Company”) (AVXT – OTCMKTS), a leading developer of proprietary cancer immunotherapy products, has signed a Settlement & Release Agreement with Cancer Treatment Centers of America Inc. (“CTCA”) to positively resolve the existing debt obligations owed to CTCA.

Under the terms of the Settlement Agreement, CTCA has agreed to settle its $5,826,464.73 Judgment against AVAX in exchange for 860,000 Series A Convertible Preferred Shares at a consideration of $5.00 per share, and a one-time payment of $1.5 million in cash. Firebird Management, a shareholder and a creditor of AVAX, has agreed to swap its outstanding debt for the Series A Convertible Preferred Shares also at a consideration of $5.00 per share.

Andrew Dahl, AVAX Board Member noted, “we are extremely happy to be able to move forward with the reorganization of AVAX’s balance sheet and look forward to re-commencing the important planned clinical trials at AVAX. Our previous work with CTCA on clinical programs has been very successful.”

Richard Rainey, Acting Chief Executive Officer of AVAX, stated, “We are pleased that throughout the development of our AC Vaccine® platform, all of our data has remained consistently positive and has supported further development of the treatment. We feel our immunotherapy platform is consistent with recently approved products and could be additive to the benefits achieved in helping patients with cancer.”

SGC Canada Inc., is acting on behalf of AVAX with its creditors in negotiating its informal restructuring plan. David Holden, the Senior Corporate Advisor of SGC states that “AVAX will be effectively debt-free once the Financial Restructuring & Refinancing Plan is completed.” The Board of AVAX has previously approved the engagement of Phoenix Corporate Finance Inc., a corporate finance firm which specializes in alternative financing, to advise, structure, and facilitate the distribution of a proposed Private Placement financing. through select securities dealers in the US and Canada. AVAX intends to raise $45 million to fund its next round of clinical testing through the issuance of the Series A Convertible Preferred Shares.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#908  Sticky Note HUGE!!! ON AVAX-TECH WEBSITE!! New Rookiemove 08/31/15 10:55:42 AM
#768  Sticky Note AVAX Announces Settlement Agreement with Cancer Treatment Centers marketraider 08/10/15 08:21:47 PM
#1146   Has anyone tried reaching out to Richard Rainey? The Flee 10/07/15 09:35:38 AM
#1145   Katter, Found this for "O-VAX" johnny canuck 10/06/15 10:31:03 PM
#1144   I googled awhile, found one place that "proposed" katter 10/06/15 05:37:42 PM
#1143   Definately Heavy shorting end of day. Probably the johnny canuck 10/06/15 05:07:54 PM
#1142   Back to .025. Go AVXT $ Rookiemove 10/06/15 02:58:34 PM
#1141   I personally don't expect to hear much of johnny canuck 10/06/15 12:09:24 PM
#1140   Ask staying strong. Just hope idiots stop playing games Jemmani 10/06/15 10:17:18 AM
#1139   AVXT Lots of games being played here during Rookiemove 10/06/15 09:09:52 AM
#1138   HAHAHAHAHA!!! I see someone is bound and determined to johnny canuck 10/05/15 03:09:41 PM
#1137   The ask never let up. This thing is Jemmani 10/02/15 04:15:14 PM
#1136   250k at .02 avxt is strong! Jemmani 10/02/15 02:36:46 PM
#1135   Amazing, no one hit that .02 yet. Rookiemove 10/02/15 02:13:47 PM
#1134   Cover time, Big Buyer at .02 Go AVXT Rookiemove 10/02/15 01:56:14 PM
#1133   Depends on the motivation, bid slowly moving Rookiemove 10/02/15 01:04:37 PM
#1132   3k shares traded. 46% move. How is Jemmani 10/02/15 12:36:46 PM
#1131   Price action looks like a stalemate, no Rookiemove 10/02/15 09:06:50 AM
#1130   That was then - this is now. johnny canuck 10/02/15 09:06:36 AM
#1129   On the bright side, the recent press release Rookiemove 10/02/15 08:54:12 AM
#1128   Not a problem, you are just asking a question. Rookiemove 10/02/15 08:41:14 AM
#1127   ON the sidelines somewhere this was posted: katter 10/01/15 11:19:54 PM
#1126   This stock is a very high risk place bayetta 10/01/15 10:09:05 PM
#1125   Error, on my part, "Please keep your post katter 10/01/15 08:31:00 PM
#1124   Would that mean you are the opposite of katter 10/01/15 08:27:51 PM
#1123   Would that mean you are the opposite of katter 10/01/15 08:27:22 PM
#1122   Hello Fifty Fifty, I like that user Id. smile. katter 10/01/15 07:29:34 PM
#1121   Hopefully a short squeeze happens! And we get huge! Jemmani 10/01/15 06:27:39 PM
#1120   I believe that is move over a holes Rookiemove 10/01/15 06:10:57 PM
#1119   Hello rookie: I'm still very new. What does FiftyFifty 10/01/15 05:54:03 PM
#1118   Thank you Johnny C and Rookie. I appreciate FiftyFifty 10/01/15 05:50:39 PM
#1117   I've learned to never count my chickens--- on"ANY" johnny canuck 10/01/15 04:26:52 PM
#1116   Fifty much depends on the magnitude of the Rookiemove 10/01/15 02:24:25 PM
#1115   Morning Johnny C. As always thanks for FiftyFifty 10/01/15 12:23:01 PM
#1114   According to OTCSHORTREPORT.COM AVXT is short between 250-600K Rookiemove 10/01/15 12:18:32 PM
#1113   Me too!! Bring on $ .50 !!!!! Rookiemove 10/01/15 12:10:53 PM
#1112   Hopefully the big move will bring a little Jemmani 10/01/15 11:34:20 AM
#1111   Found us some buyers.....looks like .03 will be Rookiemove 10/01/15 11:17:22 AM
#1110   Need a few more gaps like that! Jemmani 10/01/15 11:17:10 AM
#1109   Anyone short just got a hell of a Rookiemove 10/01/15 10:55:30 AM
#1108   Holy crap, we have us a GAPPER !! GO Rookiemove 10/01/15 10:49:50 AM
#1107   Hello Katter: my memory is a little Hazy. FiftyFifty 09/30/15 10:56:46 PM
#1106   When did it delist? I've been buying since katter 09/30/15 03:14:11 PM
#1105   3 MMs on bid now. Lets go Rookiemove 09/30/15 10:20:21 AM
#1104   Lol, add another 26K to that now. Rookiemove 09/30/15 10:19:38 AM
#1103   Someone bought 500 shares.... Jemmani 09/30/15 10:12:07 AM
#1102   Sounds good to me, very few shares on Rookiemove 09/30/15 09:26:28 AM
#1101   Let's go avxt. Let's climb the rest of Jemmani 09/30/15 09:02:18 AM
#1100   Can't see any benefit, unless shares wouldn't Rookiemove 09/29/15 03:59:40 PM
#1099   Thank you for your input rookie. Thank you FiftyFifty 09/29/15 03:42:22 PM
#1098   Bids starting to stack, lets see if AVXT Rookiemove 09/29/15 02:16:02 PM
#1097   Welcome 50/50, the PR dropped back on Aug Rookiemove 09/29/15 11:43:37 AM